SDIP Innovations, a company in residence in the Rosenman Scholar program at the UCSF Rosenman Institute, has been selected as a finalist for the prestigious national Start-Up Stadium competition organized by BIO, the world’s largest biotech trade association.

During BIO Digital Week, June 8 through 12, 2020, Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and strategic partners provide feedback and judge 6 minute pitches presented by biotech startups.

SDIP is developing a novel biomaterial platform, JAZBI, for a broad range of orthopedic and cardiovascular applications. In animal studies, JAZBI is superior to other bioresorbable materials due to its safe degradation into water and carbon dioxide, as well as complete reabsorption from bulk (inside-out), resulting in less inflammation, better healing, and stronger integration with bone. SDIP is initially focused on developing resorbable osteotomies wedges and screws for ACL reconstruction. The technology was co-invented by SDIP’s chief science officer, Dr. Iman Manavitehrani, during his PhD at the University of Sydney.

The Rosenman Scholar program provides international healthtech startups with incubator space, Bay Area connections, and mentorship at the UCSF Rosenman Institute’s location at the UCSF Mission Bay campus in San Francisco. SDIP Innovations is sponsored by the government of the New South Wales, the Australian territory.